Organometallic Compounds
Medchemexpress LLC Tolterodine (Tartrate) | 124937-52-6 | 98.6% | C26H37NO7 | 25 MG
Tolterodine tartrate is an mAChR inhibitor and a substrate for cytochrome P450 enzymes. It competitively binds acetylcholine, reducing sympathetic excitation and inhibiting involuntary bladder muscle contraction. It also restores the Nrf2/NF-κB signaling pathway, protecting against inflammatory response and ferroptosis. It is used for research on urinary tract infections and overactive bladder.
- mAChR inhibitor
- Substrate for cytochrome P450 enzymes
- Competitively binds acetylcholine
- Reduces sympathetic excitation
- Inhibits involuntary bladder muscle contraction
- Restores Nrf2/NF-κB signaling pathway
- Protects against inflammatory response and ferroptosis
- Ameliorates LPS-induced oxidative stress
- Research use for urinary tract infections and overactive bladder
Medchemexpress LLC Tolterodine (tartrate) | 124937-52-6 | 98.6% | C26H37NO7 | 5 MG
Tolterodine tartrate is an mAChR inhibitor and a substrate for cytochrome P450 enzymes. It competitively binds acetylcholine, which reduces sympathetic excitation and inhibits involuntary bladder muscle contraction. It has also shown to restore the Nrf2/NF-κB signaling pathway, providing protection against inflammatory responses and ferroptosis. This compound can ameliorate LPS-induced reactive oxygen species production and lipid oxidation, making it suitable for research on urinary tract infections and overactive bladder.
- mAChR inhibitor and cytochrome P450 substrate
- Reduces sympathetic excitation
- Inhibits involuntary bladder muscle contraction
- Restores Nrf2/NF-κB signaling pathway
- Protects against inflammatory responses and ferroptosis
- Ameliorates LPS-induced oxidative stress
- Used for urinary tract infection and overactive bladder research
Medchemexpress LLC Tolterodine tartrate | 124937-52-6 | 98.6% | C26H37NO7 | 1 ML
Tolterodine tartrate is a mAChR inhibitor and a substrate for cytochrome P450 enzymes. It competitively binds acetylcholine, which reduces sympathetic excitation and inhibits involuntary bladder muscle contraction. It restores the Nrf2/NF-κB signaling pathway, providing protection against inflammatory response and ferroptosis, and ameliorates LPS-induced reactive oxygen species production and lipid oxidation. This product can be used for research related to urinary tract infections and overactive bladder.
- Competitively binds acetylcholine
- Reduces sympathetic excitation
- Inhibits involuntary bladder muscle contraction
- Restores Nrf2/NF-κB signaling pathway
- Provides protection against inflammatory response and ferroptosis
- Ameliorates LPS-induced reactive oxygen species production and lipid oxidation
Medchemexpress LLC Tolterodine tartrate | 124937-52-6 | 98.6% | C26H37NO7 | 50 MG
Tolterodine tartrate is a muscarinic acetylcholine receptor (mAChR) inhibitor and a substrate for cytochrome P450 enzymes. It reduces sympathetic excitation and inhibits involuntary bladder muscle contraction by competitively binding acetylcholine. It also restores the Nrf2/NF-κB signaling pathway, protecting against inflammatory response and ferroptosis, making it suitable for research in urinary tract infections and overactive bladder.
- Restores Nrf2/NF-κB signaling pathway.
- Protects against inflammatory response and ferroptosis.
- Ameliorates LPS-induced reactive oxygen species production and lipid oxidation.
- Suitable for research on urinary tract infections and overactive bladder.
- Reduces LPS-induced oxidative stress and inhibits production of IL-6, IL-1β, and TNF-α.
- Attenuates LPS-induced ferroptosis.
Medchemexpress LLC Tolterodine tartrate | 124937-52-6 | 98.6% | C26H37NO7 | 100 MG
Tolterodine tartrate is a muscarinic acetylcholine receptor (mAChR) inhibitor and a substrate for cytochrome P450 enzymes. It works by competitively binding acetylcholine, reducing sympathetic excitation and inhibiting involuntary bladder muscle contraction. This compound restores the Nrf2/NF-κB signaling pathway, protecting against inflammatory responses and ferroptosis. It is used in research for urinary tract infections and overactive bladder.
- Inhibits mAChR
- Substrate for cytochrome P450 enzymes
- Reduces sympathetic excitation
- Inhibits involuntary bladder muscle contraction
- Restores Nrf2/NF-κB signaling pathway
- Protects against inflammatory responses
- Protects against ferroptosis
- Ameliorates reactive oxygen species production
- Ameliorates lipid oxidation
- Applied in urinary tract infection research
- Applied in overactive bladder research
Medchemexpress LLC Tolterodine (tartrate) | 124937-52-6 | MFCD00045558 | 98.6% | C26H37NO7 | 250 MG
Tolterodine tartrate is an mAChR inhibitor and substrate for cytochrome P450 enzymes, used in research for urinary tract infections and overactive bladder. It competitively binds acetylcholine, reducing sympathetic excitation and inhibiting involuntary bladder muscle contraction.
- Inhibits muscarinic acetylcholine receptors
- Substrate for cytochrome P450 enzymes
- Reduces sympathetic excitation
- Inhibits involuntary bladder muscle contraction
- Restores Nrf2/NF-κB signaling pathway
- Protects against inflammatory response and ferroptosis
- Ameliorates LPS-induced oxidative stress
Medchemexpress LLC Tri(amino-PEG5-amide)-amine | 2055013-52-8 | 99.86% | C45H93N7O18 | 100 MG
Tri(Amino-PEG5-amide)-amine is a PEG-based PROTAC linker designed for use in the synthesis of PROTACs. It has a high purity of 99.86% and is supplied as a viscous liquid. This chemical is ideal for laboratory applications requiring precise molecular synthesis.
- CAS Number: 2055013-52-8
- Molecular Formula: C45H93N7O18
- Purity: 99.86%
- Appearance: Viscous liquid
- Color: Colorless to light yellow
- Storage: -20°C for 3 years (pure form); -80°C for 6 months or -20°C for 1 month (in solvent)